Related Experiment Video
Updated: May 16, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Prognostics factors of renal failure in multiple sclerosis]
1Services d'urologie-transplantation, CHU Amiens Sud, Salouel cedex, France. viartludovic@gmail.com
Summary
Renal failure affects 3.3% of Multiple Sclerosis patients, particularly those with SPMS, longer disease duration, and low bladder compliance. Enhanced monitoring is recommended for these high-risk individuals.
Area of Science:
- Neurology
- Urology
- Nephrology
Context:
- Multiple Sclerosis (MS) frequently causes urinary symptoms in 50-80% of patients.
- Renal complications, including renal failure, can occur during MS progression.
- Understanding the prevalence and risk factors for renal failure in MS is crucial for patient management.
Purpose:
- To determine the prevalence of renal failure in a cohort of Multiple Sclerosis patients.
- To investigate the correlation between renal failure and specific MS disease characteristics.
- To explore the association of renal failure with urodynamic findings.
Summary:
- This study followed 121 MS patients, identifying renal failure in 3.3% (4 patients).
- Renal failure was significantly associated with secondary-progressive MS (SPMS) (EDSS >6.5), longer disease duration (>30 years), and low bladder compliance.
- Urodynamic assessment revealed detrusor overactivity, detrusor/sphincteric dyssynergia, and low bladder compliance as key factors.
Impact:
- Identifies specific patient subgroups (SPMS, long disease duration, low bladder compliance) at higher risk for renal failure.
- Suggests the need for targeted urological and renal monitoring in these high-risk MS patients.
- Provides evidence for integrating urodynamic findings into the comprehensive management of MS patients with urinary dysfunction.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...